AbbVie's strong earnings and growth projections make it a solid buy for 2025, with no major patent expirations until 2030. Learn more on ABBV stock here.

Q4 2024 Earnings Call Transcript January 30, 2025 Cigna Corporation misses on earnings expectations. Reported EPS is $6.64 ...

Q3 2025 Earnings Call Transcript January 29, 2025 Flex Ltd. beats earnings expectations. Reported EPS is $0.77, expectations were $0.64. Operator: Thank you for standing by. Welcome to Flex’s Third ...

Welcome to the OneMain Financial Fourth Quarter 2024 Earnings Conference Call and Webcast. Hosting the call today from OneMain is Peter Poillon, Head of Investor Relations. Today's call is being ...

As on 31-12-2024, the company has a total of 348.21 Crore shares outstanding.BHEL Share Price Today is Rs. 208.09. On previous day, the BHEL Share Price (NSE) closed at Rs. 199.86, featuring among the ...

Company has S R Batliboi & Associates LLP as its auditors. As on 31-12-2024, the company has a total of 6,969.98 Crore shares outstanding.Vodafone Idea Share Price Today is Rs. 9.05. On previous day, ...